Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

Study Overview
=================
Brief Summary
-----------------
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical datas to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to epithetial ovarian cancer, Fallopian tube cancer and Primitive peritoneal cancer.

Detailed Description
-----------------
A Clinical and Biological Database is a collection of reliable, prospective and representative datas. This collection, provided to the scientific community, will help to develope research programs such as : Cinicals and biological predictive factors of treatments response Identification of biological tumoral markers associate with survival Identification of prognosic factors after recidivism Diagnostics tests optimisation and follow-up from blood samples ( Circulating Tumor Cells (CTC) ) Developing strong preclinical models. Those models would be later used to test alternative treatments and would help to identify new biomarkers

Official Title
-----------------
Development of a Prospective and Monocentric Cinical and Biological Database in Epithelial Ovarian Cancer, Fallopian Tube Cancer and Primitive Peritoneal Cancer

Conditions
-----------------
Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms

Intervention / Treatment
-----------------
* Other: Biological collection


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 18 or older Patient at the diagnosis of an epithelial ovarian cancer, or a fallopian tube caner or a primitive peritoneal cancer Patient eligible for, at least, one surgery and a chemotherapy Patient having given his informed, written and express consent Exclusion Criteria: Patient not affiliated to a social protection scheme Pregnant and / or nursing women Subject under tutelage, curatorship or safeguard of justice Patient whose regular follow-up is impossible for psychological, familial, social or geographical reasons

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Biological collection<br>For all the patients include in the studie : Blood samples collected at different times : Before treatment (T1) , after chemotherapy (T2), after interval surgery (T3) and after cancer reccurence (T4) Tissue samples (tumor tissue and healthy tissue) collected during the surgery In parallel to this biological collection, standardized clinical data will be entered into a database | Other: Biological collection<br>* Blood samples collected at different times : Before treatment (T1) , after chemotherapy (T2), after interval surgery (T3) and after cancer reccurence (T4) Tissue samples (tumor tissue and healthy tissue) collected during the surgery<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Proportion of patients who gave their consent to participate in the study | The proportion of patients who consent to participate in the study among the screened patients | Until the study completion : 3 years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Biological Specimen Banks, Cancer, Gynecology